MediPharm Labs Corp. (OTCQB: MLCPF) (TSX-V: LABS) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc. has entered into purchase agreements with multiple cultivators, successfully acquiring over 5,000 KG of dried cannabis supply in the last two weeks of March […]

MediPharm Labs Corp. (OTCQB: MLCPF) (TSX-V: LABS) is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc., has entered into its first definitive international sales agreement, dated February 20, 2019, with AusCann Group Holdings Ltd. to supply private label purified, pharmaceutical grade cannabis oil concentrates, or resin, from MediPharm Labs’ own inventory of oil […]

“Buzz on the Street” Show: Featuring MediPharm Labs Cannabis News Recap MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) has entered into a significant sales agreement with a leading Licensed Producer to supply approximately $35 million of private label purified cannabis oil concentrates. Under the terms of the agreement, the Licensed Producer will immediately purchase upfront […]